Britain has signed deals to secure 90 million doses of two possible Covid-19 vaccines from an alliance of Pfizer Inc and BioNTech, and French group Valneva, the business ministry has said.
Britain secured 30 million doses of the experimental BioNTech/Pfizer vaccine, and a deal in principle for 60 million doses of the Valneva vaccine, with an option of 40 million more doses if it was proven to be safe, effective and suitable, the ministry said.
According to Reuters, with no working vaccine against Covid-19 yet developed, Britain now has three different types of vaccine under order and a total of 230 million doses potentially available.
